New research shows that after the body's defenses kill the virus behind COVID-19, leftover digested chunks of SARS-CoV-2 ...
Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ — Javelin Sciences, a pioneering certified biotechnology laboratory specializing in advanced ...
Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...
The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...
The human body is naturally equipped with defenses to fight off viral infections. For a virus to successfully infect it, it must first overcome these defenses. To do so, viruses have evolved ...
Hosted on MSN
SARS-CoV-2 protein found to spread between cells, triggering immune attack on healthy cells
A new study uncovers a surprising mechanism by which the SARS-CoV-2 virus, responsible for COVID-19, might cause immune-mediated tissue damage by targeting cells it has never infected. Published in ...
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study Group today announced the plan to initiate a Phase 2 clinical trial evaluating monoclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results